1SKF401E — Zentiva as Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Zentiva as, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2002 December 31st	2012 December 31st	2013 December 31st	2014 December 31st	2015 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	Final	Final	Final	Final
Revenue
Total Revenue	169	186	166	140	113
Cost of Revenue
Gross Profit	98.5	136	101	78.9	57.7
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	150	90.8	94.7	89.6	80
Operating Profit	18.8	95.4	71.7	50.1	33.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	11.2	94.8	71.4	50.2	33.3
Provision for Income Taxes
Net Income After Taxes	8	81.4	52.3	36	17.5
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	8	69.4	51.7	36	17.5
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	8	69.4	51.7	36	17.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.95	49.8	31.7	22.2	10.8
Dividends per Share